Definitive Contract 75N93018C00019
Award Date
7/31/18
Potential Completion Date
7/31/19
Potential Value
$222K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
HDT Bio Corp
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98102, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
16
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $216,444 Small Business Innovation Research (SBIR) Phase I contract to Crosslife Technologies Inc., a self-certified small disadvantaged business, to conduct research and development on diagnostics to enable the detection and elimination of malaria and neglected tropical diseases. The contract was awarded under the NIH/CDC SBIR Contract Solicitation PHS...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) under the Department of Health and Human Services. The contract, valued at $225,000.00, was awarded to Hemex Health Inc., a for-profit medical diagnostics company that develops affordable point-of-care tests for diseases like sickle cell and malaria. The contract is focused on developing diagnostic...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a Small Business Innovation Research (SBIR) Phase II contract to Nowdiagnostics, Inc., a small disadvantaged business, for a multiplexed remote system for filovirus disease surveillance. The firm-fixed-price contract, with a potential value of $2,431,860.00, was awarded on September 20, 2018 and has a completion date of September 30, 2022....
This is a $300,000.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Kephera Diagnostics LLC, a small business, for the discovery and validation of novel diagnostic biomarkers for malaria and select neglected tropical diseases. The contract is a Small Business Innovation Research (SBIR) Phase I award, meaning it supports early-stage research and development efforts. The work will be performed in Framingham,...
The U.S. Department of Health and Human Services, National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Definitive Contract in the amount of $299,974 to Crosslife Technologies Inc., a self-certified small disadvantaged business, for a Small Business Innovation Research (SBIR) Phase I project titled "A Rapid Nucleic Acid Test for the Point of Care Detection of Malaria." The contract was set aside for total small...
This firm-fixed-price SBIR Phase I contract was awarded by the Department of Health and Human Services' National Institute of Allergy and Infectious Diseases to HDT Bio Corp, a for-profit biopharmaceutical company. The $599,629 contract funds the "Rational Development of a Combination Nanoparticle Adjuvant for Influenza", which involves research and development of novel adjuvants and other medical countermeasures. HDT Bio Corp has previously served as a prime contractor on other HHS...
This federal contract award, valued at $299,659.00, was granted to Big Eye Diagnostics Inc., a small business manufacturer of goods, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract is part of the Small Business Innovation Research (SBIR) program and is a Definitive Contract with a Firm Fixed Price pricing type. The contract is for the development of an "easy-to-use, low-cost triplex RDT for the...
This is a $299,959 SBIR Phase I contract awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to HDT Bio Corp, a biopharmaceutical company that develops drugs and vaccines for cancer, infectious diseases, and other unmet medical needs. The contract is for research, development, testing, and manufacturing services related to HDT Bio Corp's RNA technologies, adjuvants, antibodies, nanoparticles, and other platforms to create new medical...
This is a $299,820.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Biological Mimetics, Inc. for a Phase I Small Business Innovation Research (SBIR) project to develop a CRISPR-based diagnostic test for parasites. The contract is not set aside. Biological Mimetics is a biotechnology firm that conducts research and development on infectious diseases, vaccines, diagnostics, and...
The Department of Health and Human Services, National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Phase I contract to Fluid Discovery, Inc., a for-profit small business, to develop "Multiplexed Droplet Digital Nucleic Acid Amplification Technologies for HIV Diagnosis." The $299,903 firm-fixed-price contract, which runs through July 31, 2024, supports research and development of innovative...